AMDR Statement on Voluntary Recalls of Medline Renewal Reprocessed Devices
[Washington, D.C. — March 8, 2025] — Patient safety is the medical device reprocessing industry’s highest priority. Regulated by the U.S. Food and Drug Administration (FDA), single use device reprocessors are subject to stringent regulation